Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis
- PMID: 3035219
- PMCID: PMC283682
- DOI: 10.1128/JVI.61.7.2192-2197.1987
Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis
Abstract
We examined the clonality of tumors induced by an acutely transforming retrovirus which carries a single oncogene. Contrary to our expectation, tumors induced by the Abelson murine leukemia virus (A-MuLV) showed one to four major proviral integration events. To further investigate the process by which clonality was established, we analyzed the number of cells infected and transformed by A-MuLV at various times after in vivo infection. At the midpoint of tumor latency (14 days postinfection), we found that infection of total bone marrow cells by A-MuLV was efficient and polyclonal. However, only a minority of these infected cells were transformed as assayed in cell culture, and clonal dominance had already been established in this transformed cell population. Examination of the in vitro growth properties of transformed cells recovered from preleukemic and leukemic mice indicated that preleukemic cells had lower cloning efficiencies than primary tumor cells. Our results suggest that the rate-limiting step in this system of lymphomagenesis is the initial transformation of bone marrow target cells and that these cells undergo subsequent changes in cloning ability during the course of the disease that lead to an autonomous neoplastic state.
Similar articles
-
Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential.J Virol. 1981 Nov;40(2):577-84. doi: 10.1128/JVI.40.2.577-584.1981. J Virol. 1981. PMID: 6275106 Free PMC article.
-
Multiple steps are required for the induction of tumors by Abelson murine leukemia virus.J Virol. 1989 May;63(5):1989-94. doi: 10.1128/JVI.63.5.1989-1994.1989. J Virol. 1989. PMID: 2539498 Free PMC article.
-
Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes.Mol Cell Biol. 1983 Apr;3(4):596-604. doi: 10.1128/mcb.3.4.596-604.1983. Mol Cell Biol. 1983. PMID: 6304498 Free PMC article.
-
The complexity of virus--cell interactions in Abelson virus infection of lymphoid and other hematopoietic cells.Adv Immunol. 1985;37:73-98. doi: 10.1016/s0065-2776(08)60338-7. Adv Immunol. 1985. PMID: 2988306 Review. No abstract available.
-
Abelson leukemia virus.Curr Top Microbiol Immunol. 1982;101:95-126. doi: 10.1007/978-3-642-68654-2_5. Curr Top Microbiol Immunol. 1982. PMID: 6303705 Review. No abstract available.
Cited by
-
Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations.J Virol. 2002 Sep;76(18):9046-59. doi: 10.1128/jvi.76.18.9046-9059.2002. J Virol. 2002. PMID: 12186888 Free PMC article.
-
The absence of Msh2 alters abelson virus pre-B-cell transformation by influencing p53 mutation.Mol Cell Biol. 2000 Nov;20(22):8373-81. doi: 10.1128/MCB.20.22.8373-8381.2000. Mol Cell Biol. 2000. PMID: 11046134 Free PMC article.
-
Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.J Virol. 2008 Sep;82(17):8383-91. doi: 10.1128/JVI.00348-08. Epub 2008 Jun 25. J Virol. 2008. PMID: 18579612 Free PMC article.
-
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.J Exp Med. 1999 May 3;189(9):1399-412. doi: 10.1084/jem.189.9.1399. J Exp Med. 1999. PMID: 10224280 Free PMC article.
-
Inhibition of v-Abl transformation by p53 and p19ARF.Oncogene. 1999 Dec 16;18(54):7731-9. doi: 10.1038/sj.onc.1203290. Oncogene. 1999. PMID: 10618713
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources